Pharmacists in Saint Petersburg, Florida
120 Pharmacists found in Saint Petersburg
Robert James Loranger, R.PH.
Pharmacist
900 49th St N, Saint Petersburg, FL 33710
727-327-8801 727-321-4273
Robin Fail, PHARM.D.
Pharmacist
620 10th St N Ste 101, Saint Petersburg, FL 33705
727-502-4144 727-502-4143
Dr. Robin C Padgett, PHARMD
Pharmacist
11001 Roosevelt Blvd N Ste 1400, Saint Petersburg, FL 33716
866-448-8040
Dr. Rodrique A Rodney, PHARMD
Pharmacist
Bay Pines Va 10000 Bay Pines Blvd, Saint Petersburg, FL 33744
727-398-6661 727-398-9506
Dr. Ryan Jeffrey Carpenter, PHARM. D.
Pharmacist
5767 38th Ave N, Saint Petersburg, FL 33710
727-345-7917
Dr. Samantha Marie Quigley, RPH, PHARMD
Pharmacist
5767 38th Ave N, Saint Petersburg, FL 33710
727-345-7917
Dr. Sarah Brooke Legg, PHARMD
Pharmacist
200 37th Ave N, Pharmacy, Saint Petersburg, FL 33704
727-895-7767
Dr. Scott Rothenberg
Pharmacist
3900 66th St N, Saint Petersburg, FL 33709
727-343-9265 727-343-9358
Dr. Spenser Austin Harris, PHARMD
Pharmacist
5345 66th St N, Saint Petersburg, FL 33709
727-548-5768 727-548-5761
Sukhninder Shah, RPH
Pharmacist
11001 Roosevelt Blvd N, Suite 1400, Saint Petersburg, FL 33716
866-448-8040
Suleman Bux
Pharmacist - Oncology
5801 Bayou Grande Blvd Ne, Saint Petersburg, FL 33703
954-557-8742
Dr. Suraj Patel, PHARMD
Pharmacist - Oncology
5000 Park St N, Saint Petersburg, FL 33709
727-954-8213
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.